Trial reportJMIR research protocols2026
Effect of Remote Vital Signs Monitoring in People Receiving Long-Term Oxygen Therapy: Protocol for a Randomized Controlled Trial.
Trial report in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06882265 (Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy : a Randomized Clinical Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividuals receiving long-term oxygen therapy (LTOT) are often confined to their homes and have impaired health-related quality of life (HRQoL). Despite technological advances, monitoring these individuals remains a challenge.
objectiveThis study aims to evaluate the impact of remote monitoring on HRQoL, dyspnea, health status, symptoms of anxiety and depression, and adherence to data entry via a mobile app in individuals receiving LTOT.
methodsThis randomized controlled trial will recruit 60 participants, including clinically stable adults diagnosed with chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD) who use LTOT. Participants will be randomized in a 1:1 ratio to either the control group (CG) or the intervention group (IG), stratified by diagnosis (COPD or ILD), and will be followed for 90 days. All participants will use a mobile app that serves as the central platform for remote monitoring. The app enables daily recording of physiological data, including heart rate (HR), peripheral oxygen saturation (SpO
resultsFunding and ethics approval were obtained in April 2023. Recruitment began in January 2024 and was completed in May 2026. A total of 62 participants were randomized, of whom 60 initiated follow-up and were included in the longitudinal analysis. Overall, 49 participants completed the 90-day follow-up. Data collection has been completed, and data analysis is ongoing. The results are expected to be submitted for publication in the first half of 2027.
conclusionsThis study will provide relevant evidence on the effect of remote monitoring in individuals receiving LTOT on HRQoL, dyspnea, health status, anxiety and depression, and engagement with data entry through a mobile app.
trial registrationClinicalTrials.gov NCT06882265; https://clinicaltrials.gov/study/NCT06882265.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.